Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?

Roberto Iezzi, Maurizio Pompili, Salvatore Agnes, Felice Giuliante, Francesca Romana Ponziani, Alessandra Cassano, Antonio Gasbarrini, Riccardo Manfredi, Massimo Siciliano, Brigida Eleonora Annicchiarico, Lucia Cerrito, Michele Basso, Anna Maria De Gaetano, Alessandro Posa, Francesca Carchesio, Matteo Garcovich, Gian Lodovico Rapaccini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

5 Citazioni (Scopus)

Abstract

N/A
Lingua originaleEnglish
pagine (da-a)32-37
Numero di pagine6
RivistaEuropean Journal of Radiology
Volume114
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • Aged
  • Aged, 80 and over
  • Bleeding
  • Blood Loss, Surgical
  • Carcinoma, Hepatocellular
  • Catheter Ablation
  • Chemoembolization
  • Chemoembolization, Therapeutic
  • Combined Modality Therapy
  • Combined treatment
  • Feasibility Studies
  • Female
  • HCC
  • Humans
  • Liver Neoplasms
  • Male
  • Middle Aged
  • Personalized medicine
  • Precision Medicine
  • Precision medicine
  • Prospective Studies
  • Radiofrequency ablation
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?'. Insieme formano una fingerprint unica.

Cita questo